KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Synopsys (SNPS) Capital Expenditures: 2009-2025

Historic Capital Expenditures for Synopsys (SNPS) over the last 16 years, with Jul 2025 value amounting to $38.6 million.

  • Synopsys' Capital Expenditures fell 3.51% to $38.6 million in Q3 2025 from the same period last year, while for Jul 2025 it was $139.3 million, marking a year-over-year decrease of 18.95%. This contributed to the annual value of $123.2 million for FY2024, which is 35.05% down from last year.
  • As of Q3 2025, Synopsys' Capital Expenditures stood at $38.6 million, which was down 30.55% from $55.6 million recorded in Q2 2025.
  • In the past 5 years, Synopsys' Capital Expenditures registered a high of $55.6 million during Q2 2025, and its lowest value of $4.4 million during Q4 2024.
  • Its 3-year average for Capital Expenditures is $40.7 million, with a median of $40.7 million in 2025.
  • In the last 5 years, Synopsys' Capital Expenditures spiked by 86.87% in 2023 and then crashed by 91.73% in 2024.
  • Quarterly analysis of 5 years shows Synopsys' Capital Expenditures stood at $26.8 million in 2021, then increased by 25.55% to $33.7 million in 2022, then spiked by 57.77% to $53.1 million in 2023, then slumped by 91.73% to $4.4 million in 2024, then decreased by 3.51% to $38.6 million in 2025.
  • Its Capital Expenditures was $38.6 million in Q3 2025, compared to $55.6 million in Q2 2025 and $40.7 million in Q1 2025.